Cargando…
ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
Copy number gain (CNG) and/or protein overexpression of ErbB2 have been observed in human breast cancer patients and are associated with poor prognosis. Similarly, ErbB2 overexpression has also been observed in canine mammary carcinoma; however, data on ErbB2 copy number is limited. The purposes of...
Autores principales: | SAKAI, Kosei, CHAMBERS, James Ken, UCHIDA, Kazuyuki, NAKAGAWA, Takayuki, NISHIMURA, Ryohei, YONEZAWA, Tomohiro, MAEDA, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025436/ https://www.ncbi.nlm.nih.gov/pubmed/33473058 http://dx.doi.org/10.1292/jvms.20-0483 |
Ejemplares similares
-
Alteration of somatostatin receptor 2 expression in canine mammary gland
tumor
por: SAKAI, Kosei, et al.
Publicado: (2015) -
Pathway pathology: the wnt and erbB mammary tumors
por: Rosner, A, et al.
Publicado: (2001) -
Effects of ErbB2 Overexpression on the Proteome and ErbB Ligand-specific Phosphosignaling in Mammary Luminal Epithelial Cells
por: Worthington, Jenny, et al.
Publicado: (2017) -
Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
por: Singer, Josef, et al.
Publicado: (2012) -
Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
por: Lahlou, Hicham, et al.
Publicado: (2012)